Matthew Brown is a consultant at the Royal Marsden hospital in West London and recently published research into using cannabinoids for cancer pain treatment.
Last month, the UK government gave doctors the green light to prescribe cannabis products to patients for the first time ever.
“The new Home Office guidelines determining the prescription of Medicinal Cannabis encompass the treatment of pain and nausea in cancer patients,” said founder and chief executive Geremy Thomas.
“Matthew's qualifications and research in this area add even further to the input of Sativa's top-level Medicinal Cannabis Advisory Board. Patient outcome is the clear driver in the highly sensitive and prevalent area of cancer treatment.”